findmyKOL
Clinical trialNCT04476485RecruitingObservational

Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy

SponsorShengjing HospitalEnrollment1,000Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Cancer Hospital Affiliated To Harbin Medical University

    Harbin, Heilongjiang, China

    Xuesong Chen
    Recruiting
  • the Second Hospital of Jilin University

    Changchun, Jilin, China

    Yingchao Zhang
    Recruiting
  • Dalian Municipal Central Hospital

    Dalian, Liaoning, China

    Wenbin Guo
    Recruiting
  • Panjin Liaohe Oilfield Gem Flower Hospital

    Panjin, Liaoning, China

    Hongbin Han
    Recruiting
  • Liaoning Cancer Hospital & Institute

    Shenyang, Liaoning, China

    Hong Xu
    Recruiting
  • Liaoning Tumor Hospital & Institute

    Shenyang, Liaoning, China

    Recruiting
  • People'S Hospital of Liaoning Province

    Shenyang, Liaoning, China

    Recruiting
  • Shengjing Hospital Affiliated To China Medical University

    Shenyang, Liaoning, China

    Cai-Gang Liu, MD
    Recruiting
  • Shengjing Hospital of China Medical University

    Shenyang, Liaoning, China

    Recruiting
  • Shengjing Hospital of China Medical University

    Shenyang, Liaoning, China

    Caigang LiuRong Wu
    Recruiting
  • Shengjing Hospital of China Medical University

    Shenyang, Liaoning, China

    Cai-Gang Liu, MD
    Recruiting
  • the Fourth Affiliated Hospital of China Medical University

    Shenyang, Liaoning, China

    Wei Tu
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Jul 2021
Primary completion
31 Dec 2021
Completion
31 Dec 2026
Last update posted
20 Jul 2021
Registered enrollment
1,000
Registry id
NCT04476485
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.